|
[1] Li Y,Yang H,Cao L,et al.Short-term surgical outcomes of spontaneous intracerebral hemorrhage in China from 2019 to 2021: A retrospective cohort study[J]. Lancet Reg Health West Pac,2023,39:100870. [2] Ruff IM,de Havenon A,Bergman DL,et al. 2024 AHA/ASA performance and quality measures for spontaneous intracerebral hemorrhage: A report from the american heart association/american stroke association[J]. Stroke,2024,55(7):e199-e230. [3] Wang H,Fleishman JS,Wu S,et al.cGAS-STING targeting offers novel therapeutic opportunities in neurological diseases[J]. Ageing Res Rev,2025,105:102691. [4] Tan S,Nepovimova E,Valko M,et al. The cGAS-STING pathway in senescence and aging-related diseases: Mechanisms and therapeutic opportunities[J/OL]. Cell Commun Signal,2026.https://link.springer.com/article/10.1186/s12964-026-02855-7. [5] Li Q,Song Q,Ma L,et al.The cGAS-STING pathway in cancer: Friend or foe[J]. Cell Death Dis,2026,17(1):374. [6] Wu Z,Jia RJ,Zhang Q,et al.The cGAS-STING pathway at the crossroads of neuroimmunology: Bridging innate immunity to aging and neurodegeneration[J]. Biomark Res,2026,14(1):34. [7] Wang Y,Wang Y,Gao Q,et al.Pharmacological activation of cGAS-STING pathway to reverse cancer drug resistance[J]. Pharmacol Ther,2026,280:108991. [8] Xie X,Ma G,Li X,et al.Activation of innate immune cGAS-STING pathway contributes to Alzheimer's pathogenesis in 5×FAD mice[J]. Nat Aging,2023,3(2):202-212. [9] Zhou J,Yang Y,Fang Y,et al.Targeting cGAS-STING signaling and cell death modes in cancer and autoimmune diseases[J]. Cytokine Growth Factor Rev,2025,85:56-80. [10] Zhao Y,Xu T,Wu Z,et al.Rebalancing redox homeostasis: A pivotal regulator of the cGAS-STING pathway in autoimmune diseases[J]. Autoimmun Rev,2025,24(6):103823. [11] Zhang Z,Zhou H,Ouyang X,et al.Multifaceted functions of STING in human health and disease: From molecular mechanism to targeted strategy[J]. Signal Transduct Target Ther,2022,7(1):394. [12] Xu Y,Chen C,Liao Z,et al.cGAS-STING signaling in cell death: Mechanisms of action and implications in pathologies[J]. Eur J Immunol,2023,53(9):e2350386. [13] Zhao M,Wang B,Zhang C,et al.The DJ1-Nrf2-STING axis mediates the neuroprotective effects of withaferin A in Parkinson's disease[J]. Cell Death Differ,2021,28(8):2517-2535. [14] Motwani M,Pesiridis S,Fitzgerald KA.DNA sensing by the cGAS-STING pathway in health and disease[J]. Nat Rev Genet,2019,20(11):657-674. [15] Ferecskó AS,Smallwood MJ,Moore A,et al.STING-triggered cns inflammation in human neurodegenerative diseases[J]. Biomedicines,2023,11(5):1375. [16] Huang Y,Liu B,Sinha SC,et al.Mechanism and therapeutic potential of targeting cGAS-STING signaling in neurological disorders[J]. Mol Neurodegener,2023,18(1):79. [17] Paul BD,Snyder SH,Bohr VA.Signaling by cGAS-STING in neurodegeneration,neuroinflammation,and aging[J]. Trends Neurosci,2021,44(2):83-96. [18] Wang R,Zhu Y,Liu Z,et al.Neutrophil extracellular traps promote tPA-induced brain hemorrhage via cGAS in mice with stroke[J]. Blood,2021,138(1):91-103. [19] Lood C,Blanco LP,Purmalek MM,et al.Neutrophil extracellular traps enriched in oxidized mitochondrial DNA are interferogenic and contribute to lupus-like disease[J]. Nat Med,2016,22(2):146-153. [20] Brinkmann V,Reichard U,Goosmann C,et al.Neutrophil extracellular traps kill bacteria[J]. Science,2004,303(5663):1532-1535. [21] Urban CF,Reichard U,Brinkmann V,et al.Neutrophil extracellular traps capture and kill Candida albicans yeast and hyphal forms[J]. Cell Microbiol,2006,8(4):668-676. [22] Saitoh T,Komano J,Saitoh Y,et al.Neutrophil extracellular traps mediate a host defense response to human immunodeficiency virus-1[J]. Cell Host Microbe,2012,12(1):109-116. [23] Abi Abdallah DS,Lin C,Ball CJ,et al.Toxoplasma gondii triggers release of human and mouse neutrophil extracellular traps[J]. Infect Immun,2012,80(2):768-777. [24] Branzk N,Lubojemska A,Hardison SE,et al.Neutrophils sense microbe size and selectively release neutrophil extracellular traps in response to large pathogens[J]. Nat Immunol,2014,15(11):1017-1025. [25] Walker MJ,Hollands A,Sanderson-Smith ML,et al.DNase Sda1 provides selection pressure for a switch to invasive group A streptococcal infection[J]. Nat Med,2007,13(8):981-985. [26] Juha M,Molnár A,Jakus Z,et al.NETosis: An emerging therapeutic target in renal diseases[J]. Front Immunol,2023,14:1253667. [27] Yipp BG,Kubes P.NETosis: How vital is it?[J]. Blood,2013,122(16):2784-2794. [28] Xue YX,Chen YJ,Qin MZ,et al.Microglial STING activation promotes neuroinflammation and pathological changes in experimental mice with intracerebral haemorrhage[J]. Acta Pharmacol Sin,2025,46(9):2376-2392. [29] Sheng W,Wu Z,Wei J,et al.Astrocyte-derived CXCL10 exacerbates endothelial cells pyroptosis and blood-brain barrier disruption via CXCR3/cGAS/AIM2 pathway after intracerebral hemorrhage[J]. Cell Death Discov,2025,11(1):373. [30] Wang Y,Yin X,Zhang X,et al.Inhibition of cGAS reduces brain injury and facilitates neurological recovery via the STING-mediated signaling pathway after germinal matrix hemorrhage in neonatal mice[J]. J Integr Neurosci,2025,24(8):39286. [31] He J,Qin Z,Cai Y,et al.USP11-PGAM5 axis promotes neurotoxic astrocyte reactivity by aggravating the mtDNA-cGAS-STING pathway after intracerebral hemorrhage[J]. Adv Sci (Weinh),2026,13(1):e14283. [32] Yang G,Kantapan J,Mazhar M,et al.Pretreated MSCs with ironQ transplantation attenuate microglia neuroinflammation via the cGAS-STING signaling pathway[J]. J Inflamm Res,2024,17:1643-1658. [33] Ouyang Y,Yu L,Shi Y,et al.Puerarin attenuates white matter injury and blood-brain barrier disruption after intracerebral hemorrhagic Stroke via cGAS-STING Axis[J]. Biology (Basel),2026,15(3):277.
|